FDA Issues Guidance on Off-Label Use Information

The FDA has updated its guidance on ways in which drug and device manufacturers can distribute peer-reviewed information about off-label uses of medical products. The draft guidance offers a checklist for manufacturers to meet before scientific or medical journals can flow from sales representatives to physicians. The FDA said the information must: 

  • Be published by an organization which has an editorial board with independent expert
  • Be peer-reviewed
  • Be an unabridged reprint
  • Be distributed with approved labeling
  • Be distributed separately from promotional information
  • Include opposing views -- when available -- regarding the unapproved use

Read the full story

More News:

All news »

What are your comments?

You cannot post comments until you have logged in. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments